Background. Dientamoeba fragilis is commonly identified in children in primary care and is suspected to cause gastrointestinal disease. Objective. To determine the association between D. fragilis colonization and gastrointestinal symptoms in children. Methods. We performed a cross-sectional study with children who presented in primary care with gastrointestinal symptoms. The associations between D. fragilis colonization and specific symptoms were explored by means of logistic regression analyses. Asymptomatic siblings of these cases were invited as control subjects for a case-control analysis, where we explored the association between D. fragilis and gastrointestinal symptoms with conditional logistic regression analysis. Results. In the cross-sectional study, 107 children were included. Their median age was 9 years (interquartile range = 6-12) and 38 (35.5%) were boys. Colonization of D. fragilis was present in 59 children (55.1%). The absence of D. fragilis was associated with soft to watery stool [odds ratio (OR) = 0.29; 95% confidence interval (CI) = 0.10-0.85], chronic diarrhoea (OR = 0.42; 95% CI = 0.18-0.97) and fatigue (OR = 0.45; 95% CI = 0.20-0.99). The case-control analyses included 44 children in each group. Dientamoeba fragilis colonization was not observed more often in cases than in controls after adjustment for age and sex (OR = 1.02; 95% CI = 0.28-3.65). Conclusion. Dientamoeba fragilis is a common parasite in children with and without gastrointestinal symptoms. The anomalous finding of the association between the absence of D. fragilis with soft to watery stools, chronic diarrhoea and fatigue are inexplicable. Our study suggests that D. fragilis colonization does not increase the risk for gastrointestinal symptoms.
Introduction
Gastrointestinal symptoms in children are common in primary care (1) . In these children, the GP often investigates the faeces for enteric parasites. One of these enteric organisms is the common protozoan parasite Dientamoeba fragilis. The reported prevalence of D. fragilis varies worldwide in different populations between 0.3% and 52% (2) . Colonization of D. fragilis in children is presumed more frequently associated with clinical symptoms opposed to colonizations in adults (3, 4) .
The pathogenicity has been discussed ever since Jepps and Dobell first described this parasite in 1918 (5) . They considered D. fragilis to be harmless, based on the absence of clinical symptoms in one out of seven patients. Others also reported asymptomatic D. fragilis colonizations (3) . Conversely, most studies describe that D. fragilis is present in children with clinical symptoms (abdominal pain, diarrhoea, constipation, nausea, vomiting and fatigue) and that symptoms disappear after treatment (6) . However, these studies were often performed without a control group, and selection bias may have occurred. In a recently published case-control study, no association between D. fragilis and chronic abdominal pain in children referred to specialist care was found (7) .
For daily primary care practice, two questions are of interest. First, within the group of patients consulting for gastrointestinal symptoms, it is of interest to know if D. fragilis colonization is associated with clinical symptoms. Second, it is important to elucidate if D. fragilis is a pathogen that requires treatment. As most requests for laboratory detection of stool pathogens are done by GPs (4), it is of utmost importance that these questions are evaluated within a primary care population. Therefore, we investigated the association between D. fragilis colonization and symptoms in children presenting with gastrointestinal symptoms in primary care. In addition, we evaluated whether D. fragilis colonization is a determinant of gastrointestinal symptoms in children in primary care.
Methods

Study design and patients
To investigate the association between D. fragilis and specific symptoms, we conducted a cross-sectional study. To study if D. fragilis colonization is a determinant of gastrointestinal symptoms, we conducted a case-control study. In both studies, written informed consent was obtained from all parents of included subjects aged 4-18 years and from children aged ≥12 years. The Medical Ethics Review Committee of the University Medical Center Groningen approved the cross-sectional study and confirmed that inclusion of a control group did not require approval according to the Dutch Medical Research Involving Human Subject Act (WMO).
Cross-sectional study
In the cross-sectional study, we recruited children who presented with abdominal pain and/or diarrhoea in primary care in the northern part of the Netherlands between July 2011 and July 2013. This was part of a prospective diagnostic study in which the primary aim was to establish the diagnostic value of faecal calprotectin for inflammatory bowel disease (8) . We included children aged 4-18 years who consulted their GP with chronic diarrhoea (≥2 weeks or ≥2 episodes of soft to watery stool in the past 6 months) or chronic abdominal pain (≥2 episodes of abdominal pain in the past 6 months). Soft to watery stool was defined as score 5, 6 or 7 of the Bristol Stool Form Scale (9) . Exclusion criteria were a diagnosis of a chronic organic gastrointestinal disease prior to inclusion, evaluation of gastrointestinal symptoms in the preceding 6 months including endoscopy or faecal calprotectin measurement, chronic use of antibiotics, nonsteroidal anti-inflammatory drugs or oral corticosteroids, or inability to complete questionnaires due to language or cognitive problems.
Case-control study
Children with gastrointestinal symptoms who were included in the cross-sectional study and who reported to have a sibling were eligible to participate as case in the case-control study. Siblings of the cases were invited to serve as controls if aged 4-18 years and when parents denied these siblings to have experience diarrhoea or abdominal pain in the preceding 3 months. Control subjects were included between March 2013 and January 2014. As we considered cases and controls to be matched pairs, cases were only included in the case-control study if their sibling agreed to participate.
Based on literature and preliminary data of the cross-sectional study, we estimated D. fragilis colonization proportions of 42% and 18% in children with and without gastrointestinal symptoms, respectively (3, 8, 10) . With a power of 80% (alpha: 0.05, two tailed), a sample size of 56 pairs was required to detect a difference of 24%.
Data collection
Participants completed the Dutch version of the Questionnaire on Pediatric Gastrointestinal Symptoms ROME III (QPGS-RIII) parent report. The ROME III criteria were used to classify the children with functional gastrointestinal disorders into three groups: functional abdominal pain, irritable bowel disease and functional constipation. The English version has good content validity and test-retest reliability (11) . Furthermore, the parent or child (if aged ≥10 years) completed a symptom questionnaire. The symptom questionnaire was developed for the prospective diagnostic study with cooperation with experienced paediatric gastroenterologists and GPs, and we used part of the questions for this study: consistency of faeces and the presence of chronic diarrhoea, chronic abdominal pain, fever, rectal blood loss, loss of appetite, awaken because of defaecation and fatigue (see Supplementary Data S1 for the short version of the children's symptoms questionnaire).
Detection of D. fragilis
All participants in both studies collected a stool sample at home and sent it to the laboratory in a sealed envelope by regular mail. Realtime polymerase chain reaction (rtPCR) was performed for detection of D. fragilis, and cycle threshold (CT) values were recorded (12) . Multiplex PCR runs included negative extraction controls, positive and PCR mix controls. Specimens were spiked with the phocine herpesvirus (PhHV) as internal controls. A rtPCR test was considered inhibited when the CT value for PhHV exceeded 2 SD of the CT value of uninhibited specimens. Dientamoeba fragilis-positive samples CT value (≤40) were arbitrarily categorized as weakly positive (CT value > 29), moderately positive (CT value between 20 and 29) and strongly positive (CT value < 20). Stool samples of children with gastrointestinal symptoms were analysed upon arrival in the laboratory, and samples of control subjects were stored at −80°C and analysed in bulk at the end of the inclusion period. The freezing of the stool samples does not affect the CT value of D. fragilis.
Statistical analyses
Cross-sectional study In the cross-sectional study, associations between D. fragilis with age, sex, specific symptoms, and functional gastrointestinal disorders were explored by means of bivariable logistic regression analyses. Results are expressed as odds ratios (OR) with corresponding 95% confidence intervals (CIs). We compared the CT-value distribution of children with diarrhoea and constipation with a Mann-Whitney U-test.
Case-control study
To evaluate if the cases included in the case-control study were representative, we compared these cases with children in the cross-sectional study who could not deliver a control. Next, we evaluated the association between D. fragilis and gastrointestinal symptoms with conditional logistic regression analysis as we considered siblings to be matched controls. Based on literature, we adjusted for age and sex (2, 4 
Results
Cross-sectional study
Of 131 eligible children, 115 children gave informed consent, of whom 108 (93.9%) provided a stool sample. The rtPCR of one stool sample was inhibited, and therefore, this patient was excluded. Mean age of the 107 children was 9 years (interquartile range = 6-12) and 38 (35.5%) were boys.
A total of 59 (55.1%) children tested positive for D. fragilis. Twenty-nine samples tested weakly positive, 30 samples were moderately positive and none were strongly positive. Associations between D. fragilis with demographic factors, symptoms and functional gastrointestinal disorders are shown in Table 1 . Watery loose stools, chronic diarrhoea and fatigue were associated with the absence of D. fragilis, with OR of 0.29 (95% CI = 0.10-0.85); 0.42 (95% CI = 0.18-0.97) and 0.45 (95% CI = 0.20-0.99), respectively. We observed the highest OR for functional constipation, although not significant [OR = 3.44 (95% CI = 0.9-13.13)]. There was no significant difference between the CT value of children with soft to watery stool or chronic diarrhoea and constipation [Mann-Whitney U-test; P = 0.616 (soft to watery stool) and P = 0.746 (chronic diarrhoea)].
Case-control study
Eighty-nine of the 107 children included in the cross-sectional analysis reported to have one or more siblings and were contacted. For 37 cases, no sibling could be included due to refusal of the sibling to participate (n = 18), the presence of gastrointestinal symptoms (n = 7) or not aged between 4 and 18 years (n = 12). Eight siblings committed to participate but did not return a stool sample, leaving 44 siblings for inclusion as a control subject. The only difference between cases with and without a control subject was that the first group contained fewer patients with chronic diarrhoea and irritable bowel syndrome and more patients with functional constipation (Table 2) . Table 2 shows the characteristics of participants in the case-control study. Dientamoeba fragilis colonization was not observed more often in cases than in controls (OR = 1.17; 95% CI = 0.39-3.47). Adjustment for age and sex did not change this result (OR = 1.02; 95% CI = 0.28-3.65). There was no significant difference between the median CT value of the cases and controls (Mann-Whitney U-test; P = 0.098). Although control subjects were selected based on the absence of diarrhoea or abdominal pain, 20 children reported symptoms ( Table 2 ). Children with these symptoms in the control group were as often colonized with D. fragilis than those without (OR = 1.13; 95% CI = 0.32-3.9).
Discussion
In this cross-sectional study of 107 children presenting with gastrointestinal symptoms in primary care, we demonstrated that the absence of D. fragilis was significantly associated with soft to watery stools, chronic diarrhoea and fatigue. The anomalous findings of these associations are inexplicable. The highest, although not significant, association (OR = 3.44) between the presence of D. fragilis and specific clinical symptoms was found for functional constipation. In the case-control study, we observed no relationship between D. fragilis colonization and gastrointestinal symptoms in children.
Our cross-sectional study showed that D. fragilis is a frequently detected parasite in children with gastrointestinal symptoms, with a prevalence of 55%. Other recently published studies demonstrated a prevalence of 43% and 46% in symptomatic children (4,7). The slightly higher prevalence in our study might be the result of selecting patients from primary care. One study showed a higher prevalence of D. fragilis in faeces samples from patients in primary care as compared to patients in secondary/tertiary care (4). This difference is most likely caused by the higher chance of having received treatment once referred to specialist care. Earlier studies showed a lower prevalence of ~10% in children (3), which may be due to differences in detection methods. The rtPCR, the current gold standard technique for detection of D. fragilis, is more sensitive than light microscopy. Studies using the latter technique probably underestimated the prevalence (13) .
Opposed to earlier studies, we demonstrated that colonization with D. fragilis was not positively associated with several gastrointestinal symptoms (6) . Our results are consistent with a recently published case-control study (7) . Surprisingly, we found an association between D. fragilis and bowel movement. The parasite had a positive association with functional constipation and a negative association with the soft to watery stool and chronic diarrhoea. This associations need to be interpreted with caution, because the small sample size of our study gives wide CIs and the association was not significant. A Danish study also reported an association of D. fragilis with a reduced frequency of bowel movements in adults (14) . We posited the theory that rapid bowel movement or soft to watery stool could reduce D. fragilis colonization. Following this theory, children with diarrhoea would have higher CT values of D. fragilis (lower parasite load) than children with constipation. However, in our study, we found no difference in CT values between diarrhoea and constipation. Another explanation for our finding could be that D. fragilis colonization is favoured by the faecal microbiome of children with constipation and not diarrhoea (15) . Studies are needed to investigate this hypothesis.
General symptoms such as fatigue have also been described as part of the clinical presentation of D. fragilis colonization (6). In contrast, we showed an association between the absence of D. fragilis colonization and fatigue. We do not have an explanation for this result. Assuming that D. fragilis is not a pathogen, the observed associations between the absence of D. fragilis and symptoms may reflect chance by multiple testing in the cross-sectional study.
In the case-control study, we demonstrated no association between D. fragilis colonization and the presence of gastrointestinal symptoms. Other studies reported the same result, and two studies showed even higher D. fragilis colonization in asymptomatic children compared to symptomatic children (3, 7, 16) . Moreover, two population-based case-control studies showed that D. fragilis was detected less frequently in patients with gastrointestinal symptoms compared to asymptomatic population (17, 18) . Apart from colonization, the parasite load might be a factor that needs to be considered. Possibly children who experience gastrointestinal symptoms have a higher parasite load compared to asymptomatic controls. However, we observed no difference in CT value between cases and controls, which is in line with another study (7) . Remarkably, none of the included children tested strongly positive (high parasite load). It might be that only a high parasite load, possibly after recent colonization, causes symptoms. Alternatively, certain subspecies within the genus of D. fragilis or subtypes could be associated with disease, whereas others are benign (19) . In our study, no subtyping was performed.
The strength of our study is that we included children with gastrointestinal symptoms and asymptomatic siblings. We anticipated that the risk of D. fragilis colonization could be similar in paired siblings, because they live in the same environment. There is a possibility that the asymptomatic siblings are at increased risk of D. fragilis colonization, because of faecal-oral transmission. However, no clear route of transmission in humans has yet been established (20) .
A limitation is that we included fewer pairs in the case-control study than our sample size calculation suggested. Since we observed a similar presence of D. fragilis in cases and controls, it is highly Table 2 . Demographic factors, accompanying symptoms and functional gastrointestinal disorders of the children participating in the crosssectional study who were not included (n = 63) or included (n = 44) in the case-control study and the control children (n = 44)
Characteristics
Cases not included in case-control (n = 63) Cases included in case-control (n = 44) Controls (n = 44) unlikely that a sample size of 56 pairs instead of the analysed 44 pairs would result in a clinically significant difference. We defined a minimal clinically relevant difference in D. fragilis colonization of 24% between children with and without gastrointestinal symptoms based on literature. We chose this rather large difference, as in our opinion in case of a true causative relationship between D. fragilis and gastrointestinal symptoms one would expect large differences.
Although control subjects were selected on the absence of gastrointestinal symptoms, some children in the control group still reported symptoms. This might have influenced the odds of D. fragilis colonization in the control group. However, also in this group, there was no association between the parasite and gastrointestinal symptoms.
A recent placebo-controlled double-blind trial showed that treatment with metronidazole did not reduce gastrointestinal symptoms in children with D. fragilis (21) . This study also demonstrated that there was no difference in clinical outcome whether the parasite was eradicated or not. Our study further clarifies the limited role of the D. fragilis parasite in children with gastrointestinal symptoms at primary care level. We demonstrated that symptoms could not predict the presence of D. fragilis colonization. Besides, we did not find an increased risk for gastrointestinal symptoms in children with D. fragilis, even though we selected our patient cohort based on age category and symptoms that have most frequently been associated with this organism. Our study and comparable results from other studies (7, 16) suggest there is no need to detect D. fragilis in children with specific or non-specific gastrointestinal symptoms.
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